Pancreatic Cancer Research

ResearcherOntario Institute for Cancer ResearchActive in the last 2 years

Ashton Anthony Connor

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7596-3771; OpenAlex author ID A5012881959, A5122775193. Sources: OpenAlex.

Their work

Papers
18 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
74
Papers, trials and grants by year

2015: 4 papers · 2016: 2 papers · 2017: 3 papers · 2018: 3 papers · 2019: 1 paper · 2020: 3 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 18

  1. Neoadjuvant Therapy and Pancreatic Cancer Resection Outcomes: A Retrospective Analysis at a Quaternary Care Center. First author DOI 10.1016/j.jss.2026.02.012↗
  2. Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data. Co-author DOI 10.1038/s41568-021-00418-1↗
  3. Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. Co-author DOI 10.1038/s41588-019-0566-9↗
  4. Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. Co-author DOI 10.1038/s41588-020-0588-3↗
  5. A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-19-2803↗
  6. Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases. Co-author DOI 10.1016/j.ccell.2018.12.010↗
  7. Exome-Wide Association Study of Pancreatic Cancer Risk. Co-author DOI 10.1053/j.gastro.2017.10.015↗
  8. Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial. Co-author DOI 10.1158/1078-0432.ccr-17-2994↗
  9. Reflex Testing for Germline BRCA1, BRCA2, PALB2, and ATM Mutations in Pancreatic Cancer: Mutation Prevalence and Clinical Outcomes From Two Canadian Research R… Co-author DOI 10.1200/po.17.00098↗
  10. Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1001/jamaoncol.2016.3916↗
  11. Molecular Events in the Natural History of Pancreatic Cancer. First author DOI 10.1016/j.trecan.2017.04.005↗
  12. Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong? Co-author DOI 10.1080/17474124.2017.1324296↗
  13. Candidate DNA repair susceptibility genes identified by exome sequencing in high-risk pancreatic cancer. Co-author DOI 10.1016/j.canlet.2015.10.030↗
  14. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Co-author DOI 10.1038/nature19823↗
  15. Increased in vitro and in vivo sensitivity of BRCA2-associated pancreatic cancer to the poly(ADP-ribose) polymerase-1/2 inhibitor BMN 673. Co-author DOI 10.1016/j.canlet.2015.04.003↗
  16. Hereditary Pancreatic Cancer Syndromes. Co-author DOI 10.1016/j.soc.2015.06.007↗
  17. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Co-author DOI 10.1038/nm.3973↗
  18. Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. Co-author DOI 10.1053/j.gastro.2014.11.042↗

Closest collaborators

The 25 strongest of 74 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Steve Gallinger · 17 shared papers, 2015–2022 · strength 1.39
  2. George Zogopoulos · 9 shared papers, 2015–2020 · strength 0.51
  3. Robert C. Grant · 8 shared papers, 2015–2020 · strength 0.45
  4. Ayelet Borgida · 8 shared papers, 2015–2020 · strength 0.44
  5. Faiyaz Notta · 7 shared papers, 2016–2020 · strength 0.41
  6. Sandra Elisabeth Fischer · 5 shared papers, 2018–2020 · strength 0.33
  7. Grainne Mary O'Kane · 5 shared papers, 2018–2020 · strength 0.33
  8. Jennifer Jane Knox · 5 shared papers, 2018–2020 · strength 0.33
  9. Michelle Chan‐Seng‐Yue · 6 shared papers, 2016–2020 · strength 0.32
  10. Sean Patrick Cleary · 6 shared papers, 2015–2019 · strength 0.28
  11. Alyssa L. Smith · 5 shared papers, 2015–2019 · strength 0.26
  12. Gloria M. Petersen · 5 shared papers, 2015–2019 · strength 0.23
  13. Kelvin Allenson · 1 shared paper, 2026 · strength 0.23
  14. Nestor F. Esnaola · 1 shared paper, 2026 · strength 0.23
  15. Ashish Saharia · 1 shared paper, 2026 · strength 0.23
  16. Ahmed Elaileh · 1 shared paper, 2026 · strength 0.23
  17. Ahmed Osama Gaber · 1 shared paper, 2026 · strength 0.23
  18. Maen Abdelrahim · 1 shared paper, 2026 · strength 0.23
  19. Kirk Heyne · 1 shared paper, 2026 · strength 0.23
  20. Youssef E. Dib · 1 shared paper, 2026 · strength 0.23
  21. Spring Holter · 4 shared papers, 2015–2018 · strength 0.20
  22. Sangeetha N. Kalimuthu · 3 shared papers, 2017–2020 · strength 0.18
  23. David F. Schaeffer · 3 shared papers, 2015–2020 · strength 0.18
  24. Daniel John Renouf · 3 shared papers, 2015–2020 · strength 0.18
  25. Michael H. A. Roehrl · 4 shared papers, 2015–2019 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.